Unexpected Hepatotoxicity of Rifampin and Saquinavir/Ritonavir in Healthy Male Volunteers.
about
Integrated therapy for HIV and tuberculosisCurrent trends and intricacies in the management of HIV-associated pulmonary tuberculosisPharmacokinetic interaction study of ritonavir-boosted saquinavir in combination with rifabutin in healthy subjectsMetabolomic screening and identification of the bioactivation pathways of ritonavirTB and HIV Therapeutics: Pharmacology Research Priorities.Evaluation of Drug-Drug Interactions between Direct-Acting Anti-Hepatitis C Virus Combination Regimens and the HIV-1 Antiretroviral Agents Raltegravir, Tenofovir, Emtricitabine, Efavirenz, and RilpivirineDrug-Drug Interaction between the Direct-Acting Antiviral Regimen of Ombitasvir-Paritaprevir-Ritonavir plus Dasabuvir and the HIV Antiretroviral Agent Dolutegravir or Abacavir plus LamivudineCPY3A4-mediated α-hydroxyaldehyde formation in saquinavir metabolism.Saquinavir, the pioneer antiretroviral protease inhibitor.Management of individuals requiring antiretroviral therapy and TB treatment.Tuberculosis and HIV co-infection: screening and treatment strategies.The pharmacological challenges of treating tuberculosis and HIV coinfections.HIV and TB coinfection: using adjusted doses of lopinavir/ritonavir with rifampin.British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2015
P2860
Q26749428-A9E7CFB7-AFB9-44AC-AD5C-A849AA0D1F23Q28069032-21174C1F-00B1-40AF-8A71-DC887E5ACDF8Q34528955-CDC001FF-0F51-4B30-9813-0A33AE50F237Q35626853-926CEBD3-2E5B-46CC-9528-BED7C1ACE5ECQ36099838-203A574D-57CC-456D-9E56-A03A50CA2D75Q36888008-CEC97E1C-EEF3-4B5D-9801-661D979918DEQ37287684-6F9CD9EF-63A2-4D57-8923-3F18F3933509Q37550673-CFC7DB0F-9FC2-43B7-9591-82ADCBCCA4AFQ37593552-CF6F9132-D6F2-482F-92F5-F172BB73551CQ37666456-0AE925BA-272D-4E20-9B68-E8D3E82478CAQ37895251-A790D311-3DE8-4F1A-85C9-95FE4BDAEF24Q39003762-59B20875-1DB0-4C7B-B2A8-831FA3D3EA2EQ46488387-CE2FC081-B892-4BDA-8E9F-A4D17457F51CQ57180790-CB9F7FD8-8F16-482B-8287-97C5CA26EF69
P2860
Unexpected Hepatotoxicity of Rifampin and Saquinavir/Ritonavir in Healthy Male Volunteers.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Unexpected Hepatotoxicity of R ...... ir in Healthy Male Volunteers.
@en
Unexpected Hepatotoxicity of R ...... ir in Healthy Male Volunteers.
@nl
type
label
Unexpected Hepatotoxicity of R ...... ir in Healthy Male Volunteers.
@en
Unexpected Hepatotoxicity of R ...... ir in Healthy Male Volunteers.
@nl
prefLabel
Unexpected Hepatotoxicity of R ...... ir in Healthy Male Volunteers.
@en
Unexpected Hepatotoxicity of R ...... ir in Healthy Male Volunteers.
@nl
P2093
P2860
P1476
Unexpected Hepatotoxicity of R ...... ir in Healthy Male Volunteers.
@en
P2093
Christophe Schmitt
Katie Winters
Malte Schutz
Myriam Riek
Susan Grange
P2860
P356
10.1111/J.1753-5174.2009.00017.X
P577
2009-03-01T00:00:00Z